Form 13-F position report

TCR2 THERAPEUTICS INC COM (DE)

Reported by American International Group Inc

Manager portfolio Source filing
TCRR CUSIP 87808K106 Manager CIK 0000005272
Latest reported change

Reported 0 shares, down 15,143 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 13 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2022 Reduced 0 -15,143 (-100.0%) 0 $0 2022-08-12
Q1 2022 Reduced 15,143 -1,067 (-6.6%) < 0.01% $42,000 2022-05-13
Q4 2021 Reduced 16,210 -485 (-2.9%) < 0.01% $76,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

104 managers reported TCR2 THERAPEUTICS INC COM (DE) for Q2 2022.

Manager Activity Shares Change % of reported 13F Reported value Tenure
MPM ASSET MANAGEMENT LLC Unchanged 4,050,865 0 4.96% $11,748,000 14 qtrs
TANG CAPITAL MANAGEMENT LLC Added 3,641,606 +641,606 1.6% $10,561,000 2 qtrs
BIOIMPACT CAPITAL LLC Unchanged 3,370,982 0 2.72% $9,776,000 11 qtrs
VANGUARD GROUP INC Added 1,334,359 +303,462 < 0.01% $3,869,000 13 qtrs
Redmile Group LLC Unchanged 1,094,645 0 0.12% $3,174,000 14 qtrs
K2 PRINCIPAL FUND L P New 1,078,070 +1,078,070 0.34% $3,126,000 1 qtr
BlackRock Inc Reduced 1,037,694 -1,494,854 < 0.01% $3,009,000 13 qtrs
BAKER BROS ADVISORS LP Unchanged 753,064 0 0.01% $2,184,000 8 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 751,300 -691,300 < 0.01% $2,179,000 10 qtrs
Artal Group S A Unchanged 750,000 0 0.12% $2,175,000 14 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.